Advertisement
Advertisement

NAGE

NAGE logo

Niagen Bioscience, Inc. Common Stock

3.76
USD
Sponsored
-0.09
-2.34%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

3.85

+0.09
+2.37%

Niagen Bioscience, Inc. Common Stock Profile

About

Niagen Bioscience Inc. is a nicotinamide adenine dinucleotide science and healthy-aging research company. Niagen Bioscience Inc., formerly known as ChromaDex Corp., is based in LOS ANGELES.

Info & Links

CEO

Robert Fried

Headquarters

10900 Wilshire Blvd. Suite 600
Los Angeles, CA 90024, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.niagenbioscience.com

Auditor

Crowe LLP

Share holders

30

Employees

117

Niagen Bioscience, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

306.55M

Enterprise Value

241.76M

Enterprise Value/EBITDA(ttm)

14.17

Price to Earnings Ratio(ttm)

28.00

Price to Sales(ttm)

2.77

Price to Book(mrq)

4.67

Price to Cash(ytd)

22.09

Profitability

Gross Margin(ttm)

64.27%

Operating Margin(ttm)

10.87%

Profit Margin(ttm)

13.47%

Return on Equity(ttm)

21.10%

Return on Invested Capital(ttm)

26.65%

Return on Assets(ttm)

14.92%

Income Statement

Revenue(ttm)

129.42M

Revenue Per Share(ttm)

1.62

Gross Profit(ttm)

83.19M

EBITDA(ttm)3

17.06M

Net Income Available to Common(ttm)

17.38M

Diluted EPS(ttm)

0.20

Share Statistics

Beta (5Y Monthly)

2.23

52-Week Change

-61.36%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

80.08M

Dividend Yield

0.00%

Float4

72.56M

% Held by Insiders

9.39%

% Held by Institutions

15.41%

Balance Sheet

Total Cash(mrq)

64.79M

Total Cash Per Share(mrq)

0.81

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.86%

Quick Ratio(mrq)

3.83%

Book Value Per Share(mrq)

0.96

Cash Flow

Operating Cash Flow Per Share(ytd)

0.16

Free Cash Flow(ytd)

13.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement